{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:49:21Z","timestamp":1787237361095,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      Tumor-induced osteomalacia (TIO) is rare paraneoplastic disorder generally caused by small benign neoplasm. Somatostatin receptor imaging has emerged as imaging of the choice in the localization of the causative tumors in new patients with clinical diagnosis of TIO. An accurate localization of the causative tumor using somatostatin receptor imaging followed by successful surgical removal offers cure of the disease. In small percentage of the patients, however, there can be recurrent disease after the surgery. In this retrospective investigation, we tried to assess whether somatostatin receptor imaging using\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-HYNIC-TOC (\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-hydrazinonicotinyl-Tyr3-octreotide) is also useful in patients with recurrent TIO after initial successful surgery.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The images of\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-HYNIC-TOC images and clinical charts of total 18 patients with suspected recurrent TIO were retrospectively reviewed. The image findings were compared with the clinical chart, which include clinical follow-up and subsequent imaging and surgery.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among all 18 patients,\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-HYNIC-TOC imaging results were negative in 5 of them. Among these 5 patients with negative imaging study, the causes of recurrent symptoms and hypophosphatemia in 3 patients were eventually found unrelated to TIO.\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-HYNIC-TOC successfully identified either recurrent causative tumors in the same location (n = 10) or different causative tumor in other locations (n = 3) in 13 patients, which rendered a sensitivity of 86.7% (13 of 15).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The efficacy of\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-HYNIC-TOC imaging in the evaluation of patients with potential recurrent TIO is compatible to that with new patients who never received surgical resection for the culprit tumors. It can play an important role in known TIO patients who were suspected to have recurrent disease.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000002458","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T15:29:55Z","timestamp":1548257395000},"page":"209-213","source":"Crossref","is-referenced-by-count":12,"title":["99mTc-HYNIC-TOC in the Evaluation of Recurrent Tumor-Induced Osteomalacia"],"prefix":"10.1097","volume":"44","author":[{"given":"Ximin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cytogfr.2005.01.002","article-title":"FGF23 and disorders of phosphate homeostasis","volume":"16","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"bib2-20230925","first-page":"57","article-title":"Tumor induced osteomalacia: associated with elevated circulating levels of fibroblast growth factor-7 in addition to fibroblast growth factor-23","volume":"85","year":"2016","journal-title":"Clin Nephrol"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1007\/s11999-013-3178-1","article-title":"The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?","volume":"471","year":"2013","journal-title":"Clin Orthop Relat Res"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/RLU.0000000000002012","article-title":"The findings on bone scintigraphy in patients with suspected tumor-induced osteomalacia should not be overlooked","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/RLU.0b013e3180a1ad1d","article-title":"Tumor-induced osteomalacia: a case of diagnostic dilemma","volume":"32","year":"2007","journal-title":"Clin Nucl Med"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/0972-3919.119541","article-title":"Bone scintigraphic patterns in patients of tumor induced osteomalacia","volume":"28","year":"2013","journal-title":"Indian J Nucl Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.ejrad.2013.04.006","article-title":"Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan","volume":"82","year":"2013","journal-title":"Eur J Radiol"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12306-013-0293-9","article-title":"Acrylic bone cement: current concept review","volume":"97","year":"2013","journal-title":"Musculoskelet Surg"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2169\/internalmedicine.53.1213","article-title":"Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B","volume":"53","year":"2014","journal-title":"Intern Med"},{"key":"bib11-20230925","first-page":"150025","article-title":"Tumor-induced osteomalacia due to a recurrent mesenchymal tumor overexpressing several growth factor receptors","volume":"2015","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/RLU.0000000000002205","article-title":"Recurrent\/residual intracranial phosphaturic mesenchymal tumor revealed on 68Ga-DOTATATE PET\/CT","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib13-20230925","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002560000306","article-title":"Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia","volume":"30","year":"2001","journal-title":"Skeletal Radiol"},{"key":"bib14-20230925","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/RLU.0000000000002223","article-title":"Elevated 68Ga-DOTATATE activity in IgG4-related lymphadenopathy","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib15-20230925","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/RLU.0000000000000807","article-title":"Talc pleurodesis with intense 18F-FDG activity but no 68Ga-DOTA-TATE activity on PET\/CT","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib16-20230925","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/rg.352140164","article-title":"Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation","volume":"35","year":"2015","journal-title":"Radiographics"},{"key":"bib17-20230925","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/RLU.0000000000001463","article-title":"Breast fibroadenoma with increased activity on 68Ga DOTATATE PET\/CT","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib18-20230925","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1097\/RLU.0000000000002023","article-title":"68Ga DOTATATE PET\/CT imaging of elastofibroma dorsi","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib19-20230925","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/RLU.0b013e318279eb13","article-title":"Successful localization of residual culprit tumor in a case of tumor-induced osteomalacia using 68Ga-DOTANOC PET\/CT","volume":"38","year":"2013","journal-title":"Clin Nucl Med"},{"key":"bib20-20230925","first-page":"1860","article-title":"Malignant phosphaturic mesenchymal tumor of the larynx","volume":"121","year":"2011","journal-title":"Laryngoscope"},{"key":"bib21-20230925","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3892\/ol.2014.2081","article-title":"Malignant phosphaturic mesenchymal tumor of the pelvis: a report of two cases","volume":"8","year":"2014","journal-title":"Oncol Lett"},{"key":"bib22-20230925","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bone.2012.11.040","article-title":"Oncogenic osteomalacia\u2014hypophosphataemic spectrum from \u201cbenignancy\u201d to \u201cmalignancy.\u201d","volume":"53","year":"2013","journal-title":"Bone"},{"key":"bib23-20230925","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bonr.2015.11.004","article-title":"Tumor induced osteomalacia secondary to anaplastic thyroid carcinoma: a case report and review of the literature","volume":"5","year":"2016","journal-title":"Bone Rep"},{"key":"bib24-20230925","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1097\/RLU.0000000000002076","article-title":"Tumor-induced osteomalacia caused by a parotid basal cell adenoma detected by 68Ga-DOTANOC PET\/CT","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib25-20230925","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/RLU.0b013e3182a20ded","article-title":"Osteomalacia-inducing renal clear cell carcinoma uncovered by 99mTc-Hydrazinonicotinyl-Tyr3-octreotide (99mTc-HYNIC-TOC) scintigraphy","volume":"38","year":"2013","journal-title":"Clin Nucl Med"},{"key":"bib26-20230925","first-page":"139","article-title":"Dual paraneoplastic syndromes: small cell lung carcinoma-related oncogenic osteomalacia, and syndrome of inappropriate antidiuretic hormone secretion: report of a case and review of the literature","volume":"70","year":"2011","journal-title":"Hawaii Med J"},{"key":"bib27-20230925","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.2106\/JBJS.CC.16.00172","article-title":"Oncogenic osteomalacia secondary to a metastatic phosphaturic mesenchymal tumor in the talus: a case report and review of the literature","volume":"7","year":"2017","journal-title":"JBJS Case Connect"},{"key":"bib28-20230925","first-page":"2018","article-title":"Distant lung metastases caused by a histologically benign phosphaturic mesenchymal tumor","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"bib29-20230925","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/RLU.0b013e3182996293","article-title":"99mTc-HYNIC-TOC (99mTc-hydrazinonicotinyl-Tyr3-octreotide) scintigraphy identifying two separate causative tumors in a patient with tumor-induced osteomalacia (TIO)","volume":"38","year":"2013","journal-title":"Clin Nucl Med"},{"key":"bib30-20230925","first-page":"E11","article-title":"Multiple phosphaturic mesenchymal tumors associated with oncogenic osteomalacia: case report and review of the literature","volume":"89","year":"2010","journal-title":"Ear Nose Throat J"},{"key":"bib31-20230925","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1210\/jc.2013-3791","article-title":"Tumor(s) induced osteomalacia\u2014a curious case of double trouble","volume":"99","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"bib32-20230925","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/0972-3919.172344","article-title":"Diagnostic importance of contrast enhanced (18)F-fluorodeoxyglucose positron emission computed tomography in patients with tumor induced osteomalacia: our experience","volume":"31","year":"2016","journal-title":"Indian J Nucl Med"},{"key":"bib33-20230925","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejim.2005.07.003","article-title":"Detection of a mesenchymal tumor responsible for hypophosphatemic osteomalacia using FDG-PET","volume":"16","year":"2005","journal-title":"Eur J Intern Med"},{"key":"bib34-20230925","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/RLU.0b013e3181f49e69","article-title":"Interesting image. The search for primary tumor in a patient with oncogenic osteomalacia: F-18 FDG PET resolves the conundrum","volume":"35","year":"2010","journal-title":"Clin Nucl Med"},{"key":"bib35-20230925","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/cen.12426","article-title":"Functional imaging in primary tumour-induced osteomalacia: relative performance of FDG PET\/CT vs somatostatin receptor-based functional scans: a series of nine patients","volume":"81","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"bib36-20230925","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/RLU.0000000000000460","article-title":"Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib37-20230925","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/RLU.0000000000000854","article-title":"68Ga DOTATATE PET\/CT is an accurate imaging modality in the detection of culprit tumors causing osteomalacia","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib38-20230925","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jc.2016-2052","article-title":"(68)Ga-DOTATATE for tumor localization in tumor-induced osteomalacia","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"bib39-20230925","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/jc.2012-3642","article-title":"Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET\/CT","volume":"98","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201903000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T01:09:00Z","timestamp":1695604140000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201903000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002458","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}